Disappearance of Aluminic Bone Disease in a Long Term Asymptomatic Dialysis Population Restricting Al(OH)3 Intake: Emergence of an Idiopathic Adynamic Bone Disease Not Related to Aluminum
- 1 January 1989
- journal article
- research article
- Published by S. Karger AG in Nephron
- Vol. 53 (2) , 93-101
- https://doi.org/10.1159/000185718
Abstract
In dialysis centers using reverse osmosis-treated water but not restricting Al(OH)3 administration, a high prevalence of histological aluminum bone disease has been reported. To assess wether this is also the case in our center where Al(OH)3 intake has always been restricted and even completely given up after 1980 thanks to high doses of CaCO3, we reviewed 42 bone biopsies performed between 1975 and 1985 in patients dialyzed for a mean duration of 56 months. Seventeen of these patients had been dialyzed before 1978 with softened water moderately contamined by aluminum, 15 had always been dialyzed with reverse osmosis-treated water and 10 had been exclusively treated by hemofiltration. The prevalence of aluminum bone disease in the whole population was 9.5% (4 patients) and consisted only of adynamic bone disease, osteomalacia being totally absent. When the patients dialyzed with aluminum-contaminated water were excluded as well as 1 diabetic patient who had taken Al(OH)3 for 1.5 years the prevalence of aluminum bone disease was null in this population. When the whole population is considered the prevalence of the other types of bone disease was 76% for osteitis fibrosa and 14.5% for a non-aluminic adynamic bone disease (6 cases). These latter cases differed from the osteitis fibrosa group only by a relative hypoparathyroidism not explained by higher plasma concentrations and higher oral cumulative doses of calcium, magnesium and aluminum or by lower plasma concentrations of phosphate and bicarbonate. None had previous parathyroidectomy, one had an unsuccessful transplantation and one was diabetic. Iron overload was excluded by negative Perls staining. Duration of dialysis was shorter for these patients than for those with osteitis fibrosa. Conclusions: (1) In the absence of parenteral aluminum contamination, exclusion of Al(OH)3 allows to prevent completely aluminic bone disease. (2) A new uremic bone disease is described: the idiopathic adynamic bone disease associated with a relative hypoparathyroidism.Keywords
This publication has 19 references indexed in Scilit:
- The Prevalence of Bone Aluminum Deposition in Renal Osteodystrophy and Its Relation to the Response to Calcitriol TherapyNew England Journal of Medicine, 1982
- Bone Aluminum and Histomorphometric Features of Renal Osteodystrophy*Journal of Clinical Endocrinology & Metabolism, 1982
- Osteomalacia in Chronic Renal Failure: a Syndrome Previously Reported Only with Maintenance DialysisAmerican Journal of Nephrology, 1982
- HISTOLOGICAL QUANTITATION OF ALUMINUM IN ILIAC BONE FROM PATIENTS WITH RENAL-FAILURE1982
- Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralizationKidney International, 1981
- Vitamin-D-Resistant Osteomalacia in Hemodialysis Patients Lacking Secondary HyperparathyroidismAnnals of Internal Medicine, 1981
- Determination of aluminum in blood, urine, and water by inductively coupled plasma emission spectrometryAnalytical Chemistry, 1979
- OSTEOMALACIC DIALYSIS OSTEODYSTROPHY: EVIDENCE FOR A WATER-BORNE ÆTIOLOGICAL AGENT, PROBABLY ALUMINIUMThe Lancet, 1978
- Gastrointestinal Absorption of Aluminum from Aluminum-Containing AntacidsNew England Journal of Medicine, 1977
- EVIDENCE FOR ALUMINUM ABSORPTION FROM GASTROINTESTINAL-TRACT AND BONE DEPOSITION BY ALUMINUM CARBONATE INGESTION WITH NORMAL RENAL-FUNCTION1977